EU agency approves two H1N1 vaccines - Summary

Geneva/Brussels - The European Medicines Agency (EMA) on Friday approved two vaccines for the pandemic A(H1N1) virus, commonly known as  swine flu , after testing them on more than 6,000 subjects. The vaccines are Focetria, which is produced by Swiss...
Posted : Fri, 25 Sep 2009 12:11:21 GMT
By : dpa
Category : Health
News Alerts by Email ( click here )
Health News | Home
Geneva/Brussels - The European Medicines Agency (EMA) on Friday approved two vaccines for the pandemic A(H1N1) virus, commonly known as "swine flu", after testing them on more than 6,000 subjects. The vaccines are Focetria, which is produced by Swiss pharmaceutical giant Novartis, and Pandemrix, manufactured by GlaxoSmithKline.

The Swiss company had earlier issued a statement publicising the decision by the London-based EU agency.

The EMA said the European Commission in Brussels was expected to grant the products' marketing authorization "shortly".

The London-based EU agency is currently recommending a two-dose vaccination schedule, at an interval of three weeks, for adults, including pregnant women, and children from six months of age. While governments are responsible for their own national vaccination strategies, they rely on information provided by the agency.

EMA officials said they had speeded up their tests to "ensure that authorised vaccines are available before the start of the flu season in the coming autumn and winter months."

However, it stressed that its recommendations may be updated over the coming months on the basis of further data from ongoing clinical studies.

Novartis said it had developed its vaccine for swine flu using traditional influenza manufacturing processes in an egg-based formulation.

The Swiss company has already began sending the first deliveries of pandemic vaccines under quarantine to governments in Europe.

Officials in London said the vaccines recommended for authorisation contain so-called "adjuvants" - substances that enhance the immune response so that less viral material can be used in each dose of vaccine.

"They are widely used in vaccine manufacture and have a good safety record. The adjuvant in Focetria has been used in another flu vaccine since 1997 in more than 45 million doses. The adjuvant in Pandemrix has been tested in clinical trials involving several thousand subjects," the EMA said in a statement.

The agency's recommendations are based on clinical trials conducted on more than 6,000 subjects.

On Thursday, the World Health Organization said it believed the world's drugmakers could produce up to 3 billion doses of pandemic vaccine in a 12 month period.

While this would not be enough for the world's population, experts at the Geneva-based UN health agency have said not everyone will need a shot.

WHO recommends vaccinating certain sections of the health services sector, and, based on national priorities, vulnerable populations.

Copyright DPA

Share/Save/Bookmark

Article : EU agency approves two H1N1 vaccines - Summary
Print this article
Email this article

Stay Updated
News gadget on your Google homepage
Subscribe to a news feed in Google Reader


Related News

Zimbabwe children, women's health declining sharply: UNICEF
Harare - The health of Zimbabwe's children and women, particularly in the poorer parts of the country has worsened sharply, with 100 children under five dying of mostly preventable diseases each day, the United Nations said Tuesday. A survey carried ...

Belgian 'coma' patient was conscious for 23 years: reports
Brussels - A 46-year-old Belgian who doctors thought had fallen into a deep coma after a car crash in 1983 had in fact been conscious for 23 years, Belgian media reported Tuesday. Rom Houben was paralysed and declared to be in a vegetative state. But...

HIV stable in Asia but rising among women, gay men
Beijing - The rate of HIV infection has risen among women and gay men in some Asian nations but stabilized across the region in recent years, a United Nations report said on Tuesday. The proportion of women among the estimated 4.7 million people livi...

HIV infections fall 17 per cent in seven years, UN says
Beijing - New HIV infections fell by 17 per cent globally from 2001 to last year, reflecting progress towards controlling spread of the virus, the United Nations umbrella group for HIV/AIDS reported on Tuesday. The good news is that we have evidence...

Estonia confirms first swine flu fatality
Tallinn - Fears grew about the spread of the A/H1N1 flu virus, known commonly as swine flu, in the Baltic states Tuesday after Estonian health officials confirmed their first fatality as a result of the illness. A statement released by the Estonian m...

WHO warns of resurgence of avian flu virus
Manila - The World Health Organization (WHO) warned Tuesday of a possible resurgence of bird flu amid new cases of the disease in poultry in Egypt, Indonesia, Thailand and Vietnam. The Manila-based WHO Western Pacific Office said the presence of the ...

Czech Republic starts swine flu vaccination
Prague - The Czech Republic began Monday vaccinating a portion of its population against the so-called swine flu in a bid to ease a looming epidemic, health officials said. The efforts against the H1N1 influenza virus began with some hospitals vaccin...

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 

 

More Health News click here
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark

 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.